Retatrutide is a innovative medication generating substantial buzz in the obesity treatment field. This remarkable peptide, developed by researchers, functions as a combined GIP and GLP-1 target agonist. Essentially, it replicates the action of these intrinsic hormones, which control appetite and support feelings of fullness. Clinical research have